Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1060) 1060
Book Review (70) 70
Publication (17) 17
Book Chapter (5) 5
Conference Proceeding (2) 2
Book / eBook (1) 1
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (945) 945
humans (864) 864
cefoxitin - therapeutic use (702) 702
female (577) 577
adult (418) 418
male (406) 406
middle aged (339) 339
cefoxitin (254) 254
aged (241) 241
bacterial infections - drug therapy (211) 211
abridged index medicus (206) 206
anti-bacterial agents - therapeutic use (175) 175
cefoxitin - pharmacology (169) 169
surgical wound infection - prevention & control (168) 168
cefoxitin - administration & dosage (160) 160
adolescent (157) 157
microbial sensitivity tests (152) 152
antibiotics (149) 149
clinical trials as topic (147) 147
prospective studies (146) 146
premedication (145) 145
microbiology (144) 144
infectious diseases (138) 138
cefoxitin - adverse effects (131) 131
random allocation (127) 127
animals (123) 123
pharmacology & pharmacy (120) 120
cephalosporins - therapeutic use (117) 117
anti-bacterial agents - pharmacology (115) 115
pregnancy (98) 98
infections (93) 93
drug therapy, combination (88) 88
drug resistance, microbial (86) 86
drug evaluation (80) 80
double-blind method (79) 79
bacteria (78) 78
child (73) 73
postoperative complications - prevention & control (72) 72
surgery (72) 72
bacterial infections - prevention & control (69) 69
drug therapy, combination - therapeutic use (67) 67
cephamycins - therapeutic use (65) 65
drug resistance (65) 65
bacteria - drug effects (58) 58
bacterial infections - microbiology (58) 58
ampicillin - therapeutic use (56) 56
clindamycin - therapeutic use (56) 56
antibiotic prophylaxis (53) 53
gentamicins - therapeutic use (53) 53
antimicrobial agents (51) 51
cefoxitin - metabolism (51) 51
cesarean section (48) 48
metronidazole - therapeutic use (48) 48
cephalosporins (47) 47
pelvic inflammatory disease - drug therapy (46) 46
time factors (46) 46
ampicillin (45) 45
cefamandole - therapeutic use (44) 44
cefotetan - therapeutic use (44) 44
mice (44) 44
cefotetan (43) 43
child, preschool (43) 43
epidemiology (43) 43
prevalence (42) 42
acute disease (41) 41
cephalosporins - pharmacology (41) 41
hysterectomy (41) 41
infection (41) 41
infant (40) 40
aged, 80 and over (39) 39
cefotaxime - therapeutic use (39) 39
escherichia coli infections - drug therapy (39) 39
urinary tract infections - drug therapy (39) 39
antimicrobial resistance (38) 38
cefazolin - therapeutic use (38) 38
escherichia coli - drug effects (38) 38
kinetics (38) 38
retrospective studies (38) 38
anti-bacterial agents - administration & dosage (37) 37
penicillin (37) 37
risk factors (37) 37
treatment outcome (37) 37
cefoxitin - blood (36) 36
hospitals (36) 36
drug resistance in microorganisms (35) 35
injections, intravenous (34) 34
obstetrics & gynecology (34) 34
biochemical phenomena, metabolism, and nutrition (33) 33
clindamycin (33) 33
penicillins - therapeutic use (33) 33
sulbactam - therapeutic use (33) 33
surgical wound infection - microbiology (33) 33
escherichia coli (32) 32
rats (32) 32
staphylococcus infections (32) 32
bacterial proteins - genetics (31) 31
cefotaxime (31) 31
medicine, general & internal (31) 31
resistance (31) 31
beta-lactamases - metabolism (30) 30
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (888) 888
Japanese (63) 63
Italian (34) 34
German (32) 32
French (22) 22
Spanish (13) 13
Czech (3) 3
Portuguese (3) 3
Bulgarian (2) 2
Chinese (2) 2
Russian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Antibiotic Treatment of Mycobacterium abscessus Lung Disease: A Retrospective Analysis of 65 Patients
by Jeon, Kyeongman and Kwon, O Jung and Lee, Nam Yong and Kim, Bum-Joon and Kook, Yoon-Hoh and Lee, Seung-Heon and Park, Young Kil and Kim, Chang Ki and Koh, Won-Jung
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2009, Volume 180, Issue 9, pp. 896 - 902
Rationale: The optimal therapeutic regimen and duration of treatment for Mycobacterium abscessus lung disease is not well established. Objectives: To assess... 
Treatment outcome | Lung diseases | Mycobacterium abscessus | Atypical mycobacteria | lung diseases | DIAGNOSIS | INFECTIONS | NONTUBERCULOUS MYCOBACTERIA | CLARITHROMYCIN RESISTANCE | treatment outcome | CHELONAE | atypical mycobacteria | RAPIDLY GROWING MYCOBACTERIA | IN-VITRO | RESPIRATORY SYSTEM | MULTIDRUG-RESISTANT TUBERCULOSIS | SP-NOV | NODULAR BRONCHIECTASIS | CRITICAL CARE MEDICINE | Sputum - microbiology | Lung - microbiology | Cefoxitin - therapeutic use | Lung Diseases - microbiology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Lung - diagnostic imaging | Lung Diseases - drug therapy | Anti-Bacterial Agents - therapeutic use | Sputum - drug effects | Liver - drug effects | Mycobacterium Infections, Nontuberculous - microbiology | Adult | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Drug Therapy, Combination | Neutropenia - chemically induced | Chemical and Drug Induced Liver Injury - etiology | Doxycycline - adverse effects | Ciprofloxacin - adverse effects | Nontuberculous Mycobacteria - drug effects | Clarithromycin - adverse effects | Doxycycline - therapeutic use | Ciprofloxacin - therapeutic use | Anti-Infective Agents - therapeutic use | Treatment Outcome | Clarithromycin - therapeutic use | Thrombocytopenia - chemically induced | Nontuberculous Mycobacteria - isolation & purification | Amikacin - adverse effects | Amikacin - therapeutic use | Lung - drug effects | Cefoxitin - adverse effects | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus
by Koh, Won-Jung and Jeon, Kyeongman and Lee, Nam Yong and Kim, Bum-Joon and Kook, Yoon-Hoh and Lee, Seung-Heon and Park, Young Kil and Kim, Chang Ki and Shin, Sung Jae and Huitt, Gwen A and Daley, Charles L and Kwon, O. Jung
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 02/2011, Volume 183, Issue 3, pp. 405 - 410
Rationale: Mycobacterium massiliense has been recognized as a separate species from Mycobacterium abscessus; however, little is known regarding the clinical... 
Mycobacterium massiliense | Treatment outcome | Clarithromycin | Mycobacterium abscessus | Nontuberculous mycobacteria | DIAGNOSIS | BOLLETII | nontuberculous mycobacteria | clarithromycin | treatment outcome | CHELONAE | RAPIDLY GROWING MYCOBACTERIA | GENE | RESPIRATORY SYSTEM | DISEASE | SP-NOV | CYSTIC-FIBROSIS | MACROLIDE RESISTANCE | CRITICAL CARE MEDICINE | Sputum - microbiology | Cefoxitin - therapeutic use | Nontuberculous Mycobacteria - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Treatment Outcome | Clarithromycin - therapeutic use | Mycobacterium Infections, Nontuberculous - diagnosis | Microbial Sensitivity Tests | Amikacin - therapeutic use | Mycobacterium Infections, Nontuberculous - microbiology | Antibiotics, Antitubercular - therapeutic use | Female | Retrospective Studies | Drug Therapy, Combination | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials
by Savaris, Ricardo F and Fuhrich, Daniele G and Duarte, Rui V and Franik, Sebastian and Ross, Jonathan D C
Sexually Transmitted Infections, ISSN 1368-4973, 02/2019, Volume 95, Issue 1, pp. 21 - 27
ObjectiveTo assess the effectiveness and safety of antibiotic regimens used to treat pelvic inflammatory disease (PID).DesignThis is a systematic review and... 
meta-analysis | systematic reviews | pelvic inflammatory disease | antibiotics | CLINDAMYCIN | INFECTIOUS DISEASES | OFLOXACIN PLUS METRONIDAZOLE | MYCOPLASMA-GENITALIUM | EFFICACY | OUTPATIENT TREATMENT | TREATMENT STRATEGIES | DOUBLE-BLIND | CEFOXITIN-DOXYCYCLINE | CIPROFLOXACIN | GENTAMICIN | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Azithromycin - therapeutic use | Pelvic Inflammatory Disease - drug therapy | Doxycycline - therapeutic use | Metronidazole - therapeutic use | Humans | Quinolones - therapeutic use | Female | Aminoglycosides - therapeutic use | Clindamycin - therapeutic use | Randomized Controlled Trials as Topic | Studies | Pain | Antibiotics | Womens health | Infertility | Pregnancy complications | Systematic review | Infections | Disease control | Inflammatory diseases | Index Medicus | Review | 1506
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Klebsiella pneumoniae Outer Membrane Porins OmpK35 and OmpK36 Play Roles in both Antimicrobial Resistance and Virulence
by Yu-Kuo Tsai and Chang-Phone Fung and Jung-Chung Lin and Jiun-Han Chen and Feng-Yee Chang and Te-Li Chen and L. Kristopher Siu
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2011, Volume 55, Issue 4, pp. 1485 - 1493
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
OVERLAP EXTENSION | IN-VIVO SELECTION | SERUM RESISTANCE | OMPF | GENE | ESCHERICHIA-COLI | PROMOTER REGION | LIVER-ABSCESS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | BETA-LACTAMASES | MUTAGENESIS INVITRO | Cefoxitin - therapeutic use | Klebsiella pneumoniae - drug effects | Ceftazidime - pharmacology | Porins - metabolism | Molecular Sequence Data | Male | Phagocytosis - genetics | Genetic Complementation Test | Cefoxitin - pharmacology | Cephalosporins - therapeutic use | Microbial Sensitivity Tests | Virulence - genetics | Klebsiella pneumoniae - genetics | Klebsiella pneumoniae - metabolism | Cephalosporins - pharmacology | Thienamycins - therapeutic use | Phagocytosis - drug effects | Klebsiella Infections - drug therapy | Porins - genetics | Bacterial Proteins - genetics | Klebsiella Infections - genetics | Thienamycins - pharmacology | Sequence Analysis, DNA | Animals | Klebsiella pneumoniae - pathogenicity | Virulence - physiology | Bacterial Proteins - metabolism | Mice | Mice, Inbred BALB C | Drug Resistance, Multiple, Bacterial - genetics | Ceftazidime - therapeutic use | Index Medicus | Mechanisms of Resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy
by Fong, Zhi Ven and McMillan, Matthew T and Marchegiani, Giovanni and Sahora, Klaus and Malleo, Giuseppe and De Pastena, Matteo and Loehrer, Andrew P and Lee, Grace C and Ferrone, Cristina R and Chang, David C and Hutter, Matthew M and Drebin, Jeffrey A and Bassi, Claudio and Lillemoe, Keith D and Vollmer, Charles M and Fernández-del Castillo, Carlos
JAMA Surgery, ISSN 2168-6254, 05/2016, Volume 151, Issue 5, pp. 432 - 439
IMPORTANCE: Wound infections after pancreaticoduodenectomy (PD) are common. The standard antibiotic prophylaxis given to prevent the infections is often a... 
ADJUVANT CHEMOTHERAPY | SURGERY | READMISSION | RISK-FACTORS | MORBIDITY | SURGICAL-SITE INFECTION | ADMINISTRATIVE DATA | SURVEILLANCE | COLON | INDEX | Perioperative Care | Cefoxitin - therapeutic use | Enterococcus faecalis - drug effects | Patient Readmission | Escherichia coli - drug effects | Humans | Drug Resistance, Bacterial | Sulbactam - therapeutic use | Male | Antibiotic Prophylaxis | Pancreaticoduodenectomy - adverse effects | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Streptococcus pneumoniae - isolation & purification | Surgical Wound Infection - drug therapy | Metronidazole - therapeutic use | Bile - microbiology | Female | Ampicillin - therapeutic use | Streptococcus pneumoniae - drug effects | Cefazolin - therapeutic use | Staphylococcus aureus - isolation & purification | Surgical Wound Infection - prevention & control | Enterococcus faecalis - isolation & purification | Home Care Services | Escherichia coli - isolation & purification | Anti-Bacterial Agents - pharmacology | Surgical Wound Infection - microbiology | Staphylococcus aureus - drug effects | Stents - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Extended Versus Narrow-spectrum Antibiotics in the Management of Uncomplicated Appendicitis in Children: A Propensity-matched Comparative Effectiveness Study
by Cameron, Danielle B and Melvin, Patrice and Graham, Dionne A and Glass, Charity C and Serres, Stephanie K and Kronman, Matthew P and Saito, Jacqueline M and Rangel, Shawn J
Annals of Surgery, ISSN 0003-4932, 07/2018, Volume 268, Issue 1, pp. 186 - 192
OBJECTIVE:The aim of this study was to compare the effectiveness of extended versus narrow spectrum antibiotics in preventing surgical site infections (SSIs)... 
SURGERY | CLOSTRIDIUM-DIFFICILE INFECTION | pediatric appendicitis | surgical site infection | GUIDELINES | AMERICAN-COLLEGE | PROPHYLACTIC ANTIBIOTICS | antibiotic stewardship | ANTIMICROBIAL RESISTANCE | APPENDECTOMY | comparative effectiveness | HEALTH-CARE | EXPOSURE | Piperacillin, Tazobactam Drug Combination - therapeutic use | Appendectomy | Cefoxitin - therapeutic use | Surgical Wound Infection - epidemiology | Humans | Child, Preschool | Male | Treatment Outcome | Surgical Wound Infection - prevention & control | Anti-Bacterial Agents - therapeutic use | Propensity Score | Ceftriaxone - therapeutic use | Comparative Effectiveness Research | Metronidazole - therapeutic use | Adolescent | Appendicitis - surgery | Female | Retrospective Studies | Drug Therapy, Combination | Patient Readmission - statistics & numerical data | Child | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Rationale for eliminating staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline
by Bard, Jennifer Dien and Hindler, Janet A and Gold, Howard S and Limbago, Brandi
Clinical Infectious Diseases, ISSN 1058-4838, 2014, Volume 58, Issue 9, pp. 1287 - 1296
Due to the ongoing concern about the reliability of Staphylococcus breakpoints (interpretive criteria) for other beta-lactam agents, the Clinical and... 
β-lactams and Staphylococcus | CLSI breakpoints | Staphylococcus susceptibility | UNITED-STATES | 3RD-GENERATION CEPHALOSPORINS | INFECTIOUS DISEASES | AUREUS BACTEREMIA | MICROBIOLOGY | DISK DIFFUSION METHOD | IMMUNOLOGY | ANTIMICROBIAL-SURVEILLANCE-PROGRAM | METHICILLIN-RESISTANT | COAGULASE-NEGATIVE STAPHYLOCOCCI | RESISTANT HETERORESISTANT STAPHYLOCOCCI | BINDING PROTEINS | IN-VITRO ACTIVITY | beta-lactams and Staphylococcus | Cefoxitin - therapeutic use | Staphylococcal Infections - drug therapy | beta-Lactam Resistance | Penicillins - therapeutic use | United States | Humans | Oxacillin - pharmacology | Staphylococcus - drug effects | Oxacillin - therapeutic use | Cefoxitin - pharmacology | Cephalosporins - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | beta-Lactams - pharmacology | Anti-Bacterial Agents - pharmacology | Penicillins - pharmacology | beta-Lactams - therapeutic use | Cephalosporins - pharmacology | United States Food and Drug Administration | Care and treatment | Oxacillin | Usage | Diagnosis | Staphylococcus | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea
by Lee, J.H and Subhadra, B and Son, Y.‐J and Kim, D.H and Park, H.S and Kim, J.M and Koo, S.H and Oh, M.H and Kim, H.‐J and Choi, C.H
Letters in Applied Microbiology, ISSN 0266-8254, 01/2016, Volume 62, Issue 1, pp. 84 - 90
Significance and Impact of the Study: As the antibiotic resistance pattern of uropathogenic Escherichia coli varies depending on different geographical... 
virulence | antimicrobial resistance | children | phylogenetic group | Escherichia coli | UTI | community | uropathogenic | Phylogenetic group | Uropathogenic Escherichia coli | Antimicrobial resistance | Children | Community UTI | Virulence | CELLS | uropathogenic Escherichia coli | PLASMID | UROSEPSIS | HOST | MICROBIOLOGY | community UTI | INDUCTION | PATHOGENICITY ISLAND | LOCUS | POLYMERASE-CHAIN-REACTION | GENE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ADHESINS | Escherichia coli Infections - drug therapy | Cefoxitin - therapeutic use | Virulence Factors - genetics | Humans | Escherichia coli Infections - microbiology | Chloramphenicol - therapeutic use | Phylogeny | Urinary Tract Infections - drug therapy | Cephalosporins - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Uropathogenic Escherichia coli - drug effects | Uropathogenic Escherichia coli - isolation & purification | Uropathogenic Escherichia coli - pathogenicity | Drug Resistance, Multiple, Bacterial | Escherichia coli Proteins - genetics | Urinary Tract Infections - microbiology | Child | Ceftazidime - therapeutic use | Republic of Korea | Drug resistance in microorganisms | Analysis | Urinary tract infections | Virulence (Microbiology) | Health aspects | Antibacterial agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A Retrospective analysis of treatment and clinical outcomes among patients with methicillin-susceptible staphylococcus aureus bloodstream isolates possessing detectable meca by a commercial PCR assay compared to patients with methicillin- resistant staphylococcus aureus bloodstream isolates
by Jones, Dylan and Elshaboury, Ramy H and Munson, Erik and Dilworth, Thomas J
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2018, Volume 62, Issue 1
mecA-positive Staphylococcus aureus isolates phenotypically susceptible to cefoxitin (mecA-methicillin-sensitive S. aureus [MSSA]) have been identified. We... 
Methicillin-resistant S. aureus | MecA-positive methicillin-susceptible S. aureus | Vancomycin | MecA PCR | Bacteremia | DIAGNOSIS | AMERICA | ADULTS | MICROBIOLOGY | mecA-positive methicillin-susceptible S. aureus | THERAPY | methicillin-resistant S. aureus | vancomycin | PHARMACOLOGY & PHARMACY | ENDOCARDITIS | mecA PCR | INFECTIOUS-DISEASES SOCIETY | bacteremia | Cefoxitin - therapeutic use | Staphylococcal Infections - drug therapy | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Middle Aged | Bacteremia - drug therapy | Bacterial Proteins - genetics | Bacteremia - mortality | Male | Penicillin-Binding Proteins - genetics | Treatment Outcome | Oxacillin - therapeutic use | Bacteremia - microbiology | Microbial Sensitivity Tests | Young Adult | Anti-Bacterial Agents - therapeutic use | Staphylococcal Infections - mortality | Vancomycin - therapeutic use | Adult | Female | Aged | Retrospective Studies | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Cefoxitin as an Alternative to Carbapenems in a Murine Model of Urinary Tract Infection Due to Escherichia coli Harboring CTX-M-15-Type Extended-Spectrum β-Lactamase
by Raphaël Lepeule and Etienne Ruppé and Patrick Le and Laurent Massias and Françoise Chau and Amandine Nucci and Agnès Lefort and Bruno Fantin
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2012, Volume 56, Issue 3, pp. 1376 - 1381
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
BACTEROIDES-FRAGILIS | IMIPENEM | PHARMACOKINETICS | BACTEREMIA | ERTAPENEM RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | SELECTION | EMERGENCE | KLEBSIELLA-PNEUMONIAE | ENTEROBACTERIACEAE | CEPHALOSPORIN | Conjugation, Genetic | Imipenem - therapeutic use | Cefoxitin - therapeutic use | Carbapenems - administration & dosage | Escherichia coli - drug effects | Humans | Ceftriaxone - pharmacology | Bacterial Load - drug effects | Cefoxitin - pharmacology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Carbapenems - pharmacology | beta-Lactamases - genetics | Ceftriaxone - administration & dosage | Female | Urinary Tract Infections - microbiology | Urinary Bladder - microbiology | beta-Lactamases - metabolism | Disease Models, Animal | Escherichia coli Infections - drug therapy | Imipenem - administration & dosage | Kidney - drug effects | Cefoxitin - administration & dosage | Drug Administration Schedule | Escherichia coli Infections - microbiology | Mutation Rate | Imipenem - pharmacology | Urinary Tract Infections - drug therapy | Kidney - microbiology | beta-Lactams - pharmacology | Animals | Ceftriaxone - therapeutic use | Carbapenems - therapeutic use | Escherichia coli - genetics | Plasmids | Urinary Bladder - drug effects | Anti-Bacterial Agents - pharmacology | Mice | beta-Lactams - therapeutic use | Anti-Bacterial Agents - administration & dosage | beta-Lactams - administration & dosage | Index Medicus | Experimental Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Identification of novel microbes associated with pelvic inflammatory disease and infertility
by Haggerty, Catherine L and Totten, Patricia A and Tang, Gong and Astete, Sabina G and Ferris, Michael J and Norori, Johana and Bass, Debra C and Martin, David H and Taylor, Brandie D and Ness, Roberta B
Sexually Transmitted Infections, ISSN 1368-4973, 09/2016, Volume 92, Issue 6, pp. 441 - 446
ObjectivesAs pelvic inflammatory disease (PID) aetiology is not completely understood, we examined the relationship between select novel bacteria, PID and... 
INFERTILITY | PELVIC INFLAMMATORY DISEASE | BACTERIAL VAGINOSIS | WOMEN | TRACT | INFECTIOUS DISEASES | MYCOPLASMA-GENITALIUM | ATOPOBIUM-VAGINAE | POLYMERASE-CHAIN-REACTION | SALPINGITIS | UREAPLASMA-UREALYTICUM | SP-NOV | ENDOMETRITIS | United States - epidemiology | Cefoxitin - therapeutic use | Prospective Studies | Doxycycline - therapeutic use | Humans | Endometritis - epidemiology | Pelvic Inflammatory Disease - epidemiology | Infertility, Female - microbiology | Vaginosis, Bacterial - drug therapy | Young Adult | Anti-Bacterial Agents - therapeutic use | Endometritis - drug therapy | Pelvic Inflammatory Disease - drug therapy | Vaginosis, Bacterial - microbiology | Adolescent | Adult | Female | Infertility, Female - prevention & control | Vagina - microbiology | Drug Therapy, Combination | Pelvic Inflammatory Disease - microbiology | Vaginosis, Bacterial - epidemiology | Endometritis - microbiology | Prevention | Ureaplasma urealyticum | Care and treatment | Sexually transmitted diseases | Pelvic inflammatory disease | Research | Index Medicus | 1506 | Epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: Results from the pelvic inflammatory disease evaluation and clinical health (peach) randomized trial
by Ness, Roberta B and Soper, David E and Holley, Robert L and Peipert, Jeffrey and Randall, Hugh and Sweet, Richard L and Sondheimer, Steven J and Hendrix, Susan L and Amortegui, Antonio and Trucco, Giuliana and Songer, Thomas and Lave, Judith R and Hillier, Sharon L and Bass, Debra C and Kelsey, Sheryl F and Study Investigators
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 05/2002, Volume 186, Issue 5, pp. 929 - 937
Pelvic inflammatory disease (PID) is a common and morbid intraperitoneal infection. Although most women with pelvic inflammatory disease are treated as... 
treatment | Pelvic inflammatory disease | pelvic pain | outpatient | inpatient | GUIDELINES | CEFOXITIN | pelvic inflammatory disease | AMPICILLIN | FERTILITY | OBSTETRICS & GYNECOLOGY | ACUTE SALPINGITIS | DOXYCYCLINE | INFECTION | Severity of Illness Index | Cefoxitin - therapeutic use | Injections, Intravenous | Cefoxitin - administration & dosage | Follow-Up Studies | Doxycycline - therapeutic use | Humans | Ambulatory Care - standards | Hospitalization | Injections, Intramuscular | Cephamycins - administration & dosage | Cephamycins - therapeutic use | Pregnancy | Anti-Bacterial Agents - therapeutic use | Doxycycline - administration & dosage | Pelvic Inflammatory Disease - physiopathology | Pelvic Inflammatory Disease - drug therapy | Adolescent | Adult | Female | Anti-Bacterial Agents - administration & dosage | Pregnancy Rate | Evaluation | Care and treatment | Ambulatory medical care | Clinical trials | Relapse | Diseases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Microbiological Characteristics of Unresolved Acute Uncomplicated Cystitis
by Kim, Hee Youn and Lee, Seung-Ju and Lee, Dong Sup and Yoo, Jae Mo and Choe, Hyun-Sop
Microbial Drug Resistance, ISSN 1076-6294, 07/2016, Volume 22, Issue 5, pp. 387 - 391
This study sought to compare the antimicrobial susceptibility rates between acute uncomplicated cystitis patients with failed initial antimicrobial treatment,... 
ANTIMICROBIAL SUSCEPTIBILITY | FEMALE OUTPATIENTS | COLLECTION | INFECTIOUS DISEASES | URINARY-TRACT-INFECTIONS | MULTICENTER | SOUTH-KOREA | RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | PREVALENCE | EPIDEMIOLOGY | Cefotaxime - therapeutic use | Recurrence | Cefoxitin - therapeutic use | Escherichia coli - drug effects | Humans | Middle Aged | Cystitis - drug therapy | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Drug Resistance, Multiple, Bacterial | Escherichia coli - pathogenicity | Treatment Failure | Adult | Female | Escherichia coli - growth & development | Escherichia coli Infections - drug therapy | Acute Disease | Ciprofloxacin - therapeutic use | Cystitis - microbiology | Escherichia coli Infections - microbiology | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Cystitis - pathology | Escherichia coli Infections - pathology | Aged | Multidrug resistant organisms | Urinary tract infections | Antimicrobial agents | Microbiology
Journal Article
Details down arrow
14. Full Text Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal
by Adhikari, R.P and Shrestha, S and Barakoti, A and Amatya, R
BMC Infectious Diseases, ISSN 1471-2334, 07/2017, Volume 17, Issue 1, pp. 483 - 483
Background: Staphylococcus aureus, an important nosocomial pathogen, is frequently associated with infections in human. The management of the infections by it... 
Inducible clindamycin resistance | Nepal | Staphylococcus aureus | MRSA | INFECTIOUS DISEASES | PREVALENCE | Prevalence | Erythromycin - pharmacology | Humans | Middle Aged | Child, Preschool | Infant | Male | Methicillin - pharmacology | Clindamycin - pharmacology | Microbial Sensitivity Tests | Young Adult | Anti-Bacterial Agents - therapeutic use | Aged, 80 and over | Macrolides - pharmacology | Adult | Female | Staphylococcal Infections - microbiology | Drug Resistance, Bacterial - drug effects | Child | Infant, Newborn | Tertiary Care Centers | Cross-Sectional Studies | Staphylococcus aureus - isolation & purification | Methicillin-Resistant Staphylococcus aureus - drug effects | Erythromycin - therapeutic use | Clindamycin - therapeutic use | Cross Infection - microbiology | Adolescent | Aged | Anti-Bacterial Agents - pharmacology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Macrolides - therapeutic use | Staphylococcus aureus - drug effects | Nepal - epidemiology | Methicillin | Drug resistance in microorganisms | Clindamycin | Analysis | Dosage and administration | Research | Prevalence studies (Epidemiology) | Health care | Linezolid | Nosocomial infection | Microbiology | Laboratories | Genes | Clinical isolates | Gram-positive bacteria | Vancomycin | Drug resistance | Incidence | Genotype & phenotype | Antibiotic resistance | Penicillin | Age | Urine | Pathogens | Staphylococcus infections | Antimicrobial agents | Erythromycin | Cefoxitin | Body fluids | Hospitals | Antibiotics | Quality control | Streptogramin B | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Hospital Epidemiology of Methicillin-Resistant Staphylococcus aureus in a Tertiary Care Hospital in Moshi, Tanzania, as Determined by Whole Genome Sequencing
by Kumburu, Happiness H and Sonda, Tolbert and Leekitcharoenphon, Pimlapas and Van Zwetselaar, Marco and Lukjancenko, Oksana and Alifrangis, Michael and Lund, Ole and Mmbaga, Blandina T and Kibiki, Gibson and Aarestrup, Frank M
BioMed Research International, ISSN 2314-6133, 2018, Volume 2018, pp. 2087693 - 12
Objective. To determine molecular epidemiology of methicillin-resistant S. aureus in Tanzania using whole genome sequencing. Methods. DNA from 33... 
MEDICINE, RESEARCH & EXPERIMENTAL | PROFILES | EVOLUTION | PATHOGEN | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MRSA | GENES | MOLECULAR EPIDEMIOLOGY | INFECTION | PREVALENCE | IDENTIFICATION | ANTIMICROBIAL RESISTANCE | Tanzania - epidemiology | Staphylococcal Infections - drug therapy | Tertiary Care Centers | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Chloramphenicol - therapeutic use | Phylogeny | Whole Genome Sequencing - methods | Molecular Epidemiology - methods | Anti-Bacterial Agents - therapeutic use | Staphylococcal Infections - epidemiology | Vancomycin - therapeutic use | Polymorphism, Single Nucleotide - genetics | Staphylococcal Infections - microbiology | Methicillin-Resistant Staphylococcus aureus - genetics | Laboratories | Genomics | Genomes | Single-nucleotide polymorphism | Vancomycin | Drug resistance | Epidemiology | Developing countries--LDCs | Gene sequencing | Methicillin | Phylogenetics | Nosocomial infections | Stains | Deoxyribonucleic acid--DNA | University colleges | Pathogens | Staphylococcus infections | Chloramphenicol | Data processing | Antimicrobial agents | Cefoxitin | Hospitals | Multilocus sequence typing | DNA sequencing | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights